Novo Nordisk

Mangoceuticals, Inc. Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”),…

Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…

One of the most compelling acquisition sagas in the pharma industry in recent times has come to an…

President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk.…

Dr. Mehmet Oz was front and center Thursday as President Donald Trump unveiled a new deal with two…

Fangzhou Inc. SHANGHAI, Nov. 07, 2025 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a…

When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…

WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by…

Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…

Pfizer on Monday said it filed a second lawsuit against Novo Nordisk and obesity startup Metsera, alleging that…

As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…

By Mrinalika Roy and Patrick Wingrove (Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most…

Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management